See more : Franklin Electric Co., Inc. (FELE) Income Statement Analysis – Financial Results
Complete financial analysis of Clinuvel Pharmaceuticals Limited (CUV.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clinuvel Pharmaceuticals Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- 8i Acquisition 2 Corp. (LAX) Income Statement Analysis – Financial Results
- Sohgo Security Services Co.,Ltd. (SOHGF) Income Statement Analysis – Financial Results
- Digital China Holdings Limited (DCHIF) Income Statement Analysis – Financial Results
- Bonäsudden Holding AB (publ) (BONAS.ST) Income Statement Analysis – Financial Results
- Shirohato Co., Ltd. (3192.T) Income Statement Analysis – Financial Results
Clinuvel Pharmaceuticals Limited (CUV.AX)
About Clinuvel Pharmaceuticals Limited
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited t to treat EPP patients with SCENESSE under a named patient program in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 88.18M | 78.32M | 65.72M | 47.98M | 32.57M | 31.05M | 25.49M | 16.77M | 6.82M | 3.32M | 2.66M | 1.55M | 722.80K | 1.04M | 0.00 | 0.00 | 0.00 | 283.31K | 754.85K | 124.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 7.73M | 27.73M | 19.10M | 12.77M | 14.13M | 445.36K | 949.77K | 615.08K | 1.94M | 5.91M | 372.14K | 166.45K | 0.00 | 0.00 | 0.00 | 916.54K | 945.44K | 957.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 80.45M | 50.59M | 46.62M | 35.20M | 18.43M | 30.60M | 24.54M | 16.15M | 4.88M | -2.59M | 2.29M | 1.39M | 722.80K | 1.04M | 0.00 | -916.54K | -945.44K | -673.86K | 754.85K | 124.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 91.23% | 64.59% | 70.93% | 73.38% | 56.60% | 98.57% | 96.27% | 96.33% | 71.61% | -78.08% | 86.03% | 89.28% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | -237.85% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 2.35M | 1.27M | 1.23M | 547.55K | 341.30K | 91.45K | 53.64K | 129.81K | 133.46K | 231.96K | 2.94M | 4.02M | 4.89M | 7.19M | 7.42M | 9.99M | 6.11M | 4.47M | 4.00M | 5.22M | 5.54M | 949.44K | 373.00K | 462.73K | 0.00 |
| General & Administrative | 1.74M | 1.32M | 1.15M | 1.10M | 1.15M | 4.78M | 6.69M | 4.88M | 5.59M | 10.51M | 4.54M | 4.52M | 4.66M | 4.92M | 5.83M | 6.21M | 8.18M | 4.53M | 4.64M | 3.16M | 1.77M | 1.35M | 1.01M | 427.94K | 0.00 |
| Selling & Marketing | 27.21M | 7.09M | 11.15M | 6.87M | 1.89M | 1.50M | 1.05M | 811.43K | 777.73K | 801.56K | 516.14K | 602.80K | 806.43K | 626.39K | 704.14K | 845.90K | 1.41M | 1.66M | 1.08M | 883.84K | 640.55K | 118.28K | 108.00K | 0.00 | 0.00 |
| SG&A | 28.95M | 8.41M | 12.30M | 7.96M | 7.89M | 6.29M | 6.34M | 5.30M | 4.70M | 5.63M | 4.86M | 5.12M | 5.46M | 5.54M | 6.54M | 7.06M | 9.59M | 6.18M | 5.72M | 4.05M | 2.41M | 1.47M | 1.12M | 427.94K | 0.00 |
| Other Expenses | 0.00 | 763.08K | 821.15K | -1.24M | 781.32K | 880.48K | 485.84K | 96.11K | 796.53K | 470.27K | 440.41K | 1.01M | -94.84K | 45.80K | 2.67M | -679.54K | -945.44K | -925.45K | 3.80M | 6.34M | 926.48K | 2.49M | 748.00K | -775.00K | 0.00 |
| Operating Expenses | 31.30M | 9.68M | 13.53M | 8.51M | 8.23M | 13.03M | 11.84M | 9.30M | 8.25M | 8.17M | 8.14M | 9.83M | 11.03M | 13.77M | 16.38M | 18.19M | 18.85M | 11.56M | 11.66M | 12.45M | 8.74M | 4.91M | 4.15M | 36.00K | 0.00 |
| Cost & Expenses | 39.03M | 37.41M | 32.64M | 21.28M | 22.37M | 13.48M | 12.79M | 9.92M | 10.18M | 14.08M | 8.52M | 9.83M | 11.03M | 13.77M | 16.38M | 19.11M | 19.79M | 12.51M | 11.66M | 12.45M | 8.74M | 4.91M | 4.15M | 36.00K | 0.00 |
| Interest Income | 7.32M | 3.91M | 444.07K | 342.20K | 562.93K | 543.54K | 242.19K | 264.39K | 208.37K | 348.41K | 326.47K | 410.46K | 571.24K | 1.18M | 1.47M | 2.67M | 4.30M | 2.24M | 446.96K | 476.94K | 355.24K | 136.40K | 258.00K | 408.70K | 0.00 |
| Interest Expense | 4.45M | 3.19M | 2.27M | 1.62M | 25.89K | 21.11K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.14M | 789.41K | 757.83K | 861.43K | 446.13K | 214.16K | 44.54K | 53.14K | 25.53K | 26.54K | 37.47K | 57.97K | 62.50K | 91.90K | 716.15K | 830.56K | 841.76K | 905.19K | 914.67K | 823.85K | 790.29K | 794.26K | 786.00K | 36.00K | 0.00 |
| EBITDA | 56.28M | 46.37M | 35.08M | 26.57M | 11.99M | 18.35M | 12.26M | 6.85M | -3.74M | -10.79M | -5.95M | -8.22M | -10.24M | -12.64M | -10.80M | -14.52M | -13.81M | -10.37M | -9.99M | -11.51M | -7.94M | -4.11M | -3.40M | -1.18M | 0.00 |
| EBITDA Ratio | 63.82% | 53.24% | 51.49% | 57.44% | 32.68% | 54.05% | 48.10% | 40.87% | -51.67% | -325.54% | -217.50% | -529.47% | -1,417.21% | -1,214.10% | 0.00% | 0.00% | 0.00% | -3,617.22% | -1,160.33% | -9,232.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 49.15M | 40.91M | 33.08M | 26.70M | 10.20M | 16.69M | 12.21M | 6.80M | -3.55M | -10.83M | -5.83M | -8.28M | -10.31M | -12.73M | -16.38M | -18.19M | -18.85M | -11.27M | -10.90M | -12.33M | -8.74M | -4.91M | -4.18M | -1.97M | 0.00 |
| Operating Income Ratio | 55.74% | 52.23% | 50.34% | 55.65% | 31.31% | 53.76% | 47.93% | 40.55% | -52.04% | -326.34% | -218.91% | -533.21% | -1,425.86% | -1,222.93% | 0.00% | 0.00% | 0.00% | -3,979.38% | -1,444.27% | -9,893.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.53M | 1.48M | -1.77M | -983.49K | -1.16M | 1.64M | 727.88K | -3.61M | 1.00M | 788.81K | 804.35K | 1.48M | 538.90K | 1.32M | 3.77M | 450.61K | 4.27M | 2.10M | 133.01K | 1.30M | 1.15M | 930.66K | 1.04M | -338.93K | 0.00 |
| Income Before Tax | 50.68M | 45.58M | 34.32M | 25.71M | 11.54M | 18.11M | 12.94M | 7.11M | -3.15M | -10.41M | -5.53M | -6.80M | -9.77M | -11.41M | -11.52M | -15.37M | -14.66M | -9.18M | -10.77M | -11.03M | -7.59M | -3.98M | -3.14M | -1.56M | -374.15K |
| Income Before Tax Ratio | 57.47% | 58.19% | 52.22% | 53.60% | 35.44% | 58.35% | 50.78% | 42.43% | -46.24% | -313.91% | -207.50% | -438.04% | -1,351.30% | -1,095.95% | 0.00% | 0.00% | 0.00% | -3,238.92% | -1,426.65% | -8,849.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 15.04M | 14.97M | 13.44M | 984.40K | -3.51M | 19.33K | 281.78K | -45.31K | -609.06K | -16.34K | 0.00 | -468.44K | -633.74K | -1.28M | -2.19M | -3.50M | -5.14M | -3.02M | -133.01K | -11.03M | -7.59M | -3.98M | -3.14M | -1.56M | -374.15K |
| Net Income | 35.64M | 30.60M | 20.88M | 24.73M | 16.65M | 18.13M | 13.22M | 7.18M | -3.12M | -10.40M | -5.53M | -6.80M | -9.77M | -11.41M | -11.52M | -15.37M | -14.66M | -9.18M | -10.77M | -11.03M | -7.59M | -3.98M | -3.14M | -1.56M | 0.00 |
| Net Income Ratio | 40.41% | 39.08% | 31.77% | 51.54% | 51.12% | 58.41% | 51.89% | 42.83% | -45.76% | -313.41% | -207.50% | -438.04% | -1,351.30% | -1,095.95% | 0.00% | 0.00% | 0.00% | -3,238.92% | -1,426.65% | -8,849.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.70 | 0.62 | 0.42 | 0.50 | 0.31 | 0.38 | 0.28 | 0.15 | -0.07 | -0.24 | -0.14 | -0.19 | -0.32 | -0.38 | -0.38 | -0.51 | -0.48 | -0.37 | -0.64 | -0.84 | -0.66 | -0.44 | -0.35 | -0.22 | -0.04 |
| EPS Diluted | 0.70 | 0.59 | 0.40 | 0.48 | 0.30 | 0.37 | 0.27 | 0.14 | -0.07 | -0.24 | -0.14 | -0.19 | -0.32 | -0.38 | -0.38 | -0.51 | -0.48 | -0.37 | -0.64 | -0.84 | -0.66 | -0.44 | -0.35 | -0.22 | -0.04 |
| Weighted Avg Shares Out | 51.05M | 49.41M | 49.41M | 49.41M | 49.26M | 48.19M | 47.74M | 47.67M | 45.29M | 43.37M | 38.70M | 35.30M | 30.76M | 30.36M | 30.32M | 30.31M | 30.24M | 24.82M | 16.77M | 13.14M | 11.44M | 9.09M | 9.03M | 7.17M | 9.03M |
| Weighted Avg Shares Out (Dil) | 51.03M | 51.82M | 51.78M | 51.13M | 50.46M | 49.60M | 49.59M | 49.63M | 45.29M | 43.37M | 38.70M | 35.30M | 30.76M | 30.36M | 30.32M | 30.31M | 30.24M | 24.82M | 16.77M | 13.14M | 11.44M | 9.09M | 9.03M | 7.17M | 9.03M |
Source: https://incomestatements.info
Category: Stock Reports